EdgarLookup

SUPERNUS PHARMACEUTICALS, INC. — Insider Transactions

Form 4 filings by directors, officers, and 10%+ shareholders

SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.

Overview All Filings Annual Quarterly Insiders
Insider Title Type Shares Price Value Owns After Date
BASKETT FOREST Other 3,000,000 7,641,250 Jun 15, 2015
KOLLURI KRISHNA KITTU Other 3,000,000 7,641,250 Jun 15, 2015
SANDELL SCOTT D Sale 55,105 $16.85 $928,519 111,881 Jun 15, 2015
NEA PARTNERS 11 LP Other 921,000 Jun 15, 2015
NEW ENTERPRISE ASSOCIATES 11 LP Other 3,000,000 7,641,250 Jun 15, 2015
Schwabe Stefan K.F. Executive Vice President R&D Sale 2,051 $18.27 $37,472 2,794 Jun 12, 2015
Schwabe Stefan K.F. Executive Vice President R&D Sale 1,345 $16.32 $21,950 7,131 Jun 11, 2015
Bryan Jones W. VP of Business Development Option Exercise 6,712 $2.56 $17,183 74,692 Mar 30, 2015
Bryan Jones W. VP of Business Development Option Exercise 25 $2.56 $64 69,880 Mar 24, 2015
Khattar Jack A. President, CEO Other 6,000 1,101,000 Mar 19, 2015
Bhatt Padmanabh P. Sr. VP of IP, CSO Option Exercise 37,500 $2.56 $96,000 107,306 Jan 15, 2015
Bhatt Padmanabh P. SR VP of IP, CSO Option Exercise 3,000 $0.40 $1,200 67,306 Jan 5, 2015
SIEBERT JOHN M Option Exercise 2,188 $4.24 $9,277 19,563 Dec 16, 2014
Khattar Jack A. President, CEO Gift 1,250 431,436 Aug 25, 2014
Khattar Jack A. President, CEO Other 7,000 1,107,000 Mar 28, 2014
SIEBERT JOHN M Option Exercise 2,187 $4.24 $9,273 17,375 Dec 12, 2013
Bhatt Padmanabh P. Sr. VP of IP; CSO Sale 2,285 $8.21 $18,760 51,806 Aug 19, 2013
Khattar Jack A. President, CEO Other 11,000 426,689 Apr 4, 2013
BIGHAM MICHAEL Purchase 5,000 $5.17 $25,850 5,000 Mar 22, 2013
SIEBERT JOHN M Purchase 3,000 $5.50 $16,500 15,188 Mar 21, 2013
Khattar Jack A. President, CEO Purchase 10,000 $6.15 $61,500 412,058 Mar 15, 2013
PATRICK GREGORY S VP, Chief Financial Officer Purchase 5,000 $6.95 $34,750 8,903 Mar 14, 2013
ISALY SAMUEL D Sale 41,100 $7.58 $311,538 817,000 Feb 13, 2013
Bhatt Padmanabh P. Sr. VP of IP; CSO Option Exercise 25,000 $0.40 $10,000 51,806 Feb 8, 2013
ORBIMED CAPITAL GP II LLC Sale 100,000 $7.08 $708,000 Dec 17, 2012
SIEBERT JOHN M Option Exercise 2,188 $4.24 $9,277 12,188 Dec 14, 2012
Martin Tami Tillotson VP of Regulatory Affairs Option Exercise 1,250 $3.36 $4,200 41,250 Dec 12, 2012
SIEBERT JOHN M Purchase 7,000 $8.14 $56,980 10,000 Dec 4, 2012
Bhatt Padmanabh P. Sr. VP of IP; CSO Option Exercise 25,000 $0.40 $10,000 25,000 Jun 18, 2012
Abingworth Management LTD Purchase 1,100,000 $5.00 $5,500,000 3,600,000 May 4, 2012
NEWHALL CHARLES W III C 6,241,250 6,241,250 May 4, 2012
BARRETT M JAMES C 6,241,250 6,241,250 May 4, 2012
SANDELL SCOTT D C 6,241,250 6,241,250 May 4, 2012
ORBIMED CAPITAL GP II LLC C 206,816 206,816 May 4, 2012
PATRICK GREGORY S VP, Chief Financial Officer Purchase 3,000 $5.00 $15,000 3,000 May 4, 2012
SIEBERT JOHN M Purchase 3,000 $5.00 $15,000 3,000 May 4, 2012
Hudson Frederick M. Purchase 5,000 $5.00 $25,000 5,000 May 4, 2012
Khattar Jack A. President, CEO Purchase 5,000 $5.00 $25,000 402,058 May 4, 2012
Nuerge William A. Purchase 15,000 $5.00 $75,000 23,750 May 4, 2012
SHEFFERY MICHAEL B C 206,816 206,816 May 4, 2012
Martin Tami Tillotson VP of Regulatory Affairs Purchase 2,500 $5.00 $12,500 2,500 May 4, 2012